BioSynthema specializes in receptor targeted peptides which have diagnostic and therapeutic applications.

BioSynthema carries out research at its R&D laboratory in St. Louis, and in addition collaborates with some of the top researchers and clinicians in the field of molecular imaging and therapy using proprietary peptides.

See references listed in Literature to see more about BioSynthema's research activities.

Somatostatin Receptor Targeted Therapy

• Information on this exciting technology coming soon - in the meantime see our press release in the news section.